Abstract
Urinary tract infections (UTI) are second only to respiratory tract infections as problems encountered by practicing physicians. They occur most often in young healthy adult women and are easy treatable in these patients. However, in some patient groups infections occur more often, can have a complicated course, are more difficult to treat and often recur. Many of them have easily recognisable urological abnormalities, but also more subtle conditions as age over 65 years, treatment with immunosuppressive drugs, HIV-infection with a CD4+ count below 200/mm3 and last but not least diabetes mellitus lead to an enhanced susceptibility for UTI. Besides organ complications as retinopathy, nephropathy and neuropathy, infections are common problems in these patients. UTI complications (e.g., bacteremia, renal abscesses, and renal papillary necrosis) occur more often in diabetic patients. We recently have completed a study in 636 non-pregnant women with DM (in- and outpatients and diabetics visiting their GP). The prevalence of asymptomatic bacteriuria was 26% compared to 6% in the control group (p<0,001). The prevalence of asymptomatic bacteriuria in the 378 women with DM type 2 was 29% (compared to 21% in those with DM type I). Therefore, the prevalence of asymptomatic bacteriuria is consistently higher in diabetic women than in non-diabetics. In the study mentioned above risk factors for asymptomatic bacteriuria in all women with DM were retinopathy, macroalbuminuria, a longer duration of the diabetes, a lower body mass index, and a symptomatic UTI in the previous year (p<0,05). Risk factors for asymptomatic bacteriuria in the women with type I diabetes included a longer duration of the diabetes, peripheral neuropathy, and macroalbuminuria. The prevalence of asymptomatic bacteriuria was 29% in women with DM type II. Risk factors in these women included age, macroalbuminuria, a lower body mass index, and a UTI in the previous year. All p-va-lues were adjusted for age. There was no association between the diabetes regulation and the presence of a post-voiding bladder residue and the presence of asymptomatic bacteriuria. We followed the cohort mentioned before for 18 months. Of these 589 women, 115 (20%) developed a symptomatic UTI. Women with DM type II and asymptomatic bacteriuria at baseline had an increased risk of developing UTI, compared to women with DM type II without asymptomatic bacteriuria at baseline (p=0,005). There was no difference in the incidence of a symptomatic UTI between DM type I women with and those without asymptomatic bacteriuria. DM type I women with asymptomatic bacteriuria had tendency to a faster decline in renal function than those without asymptomatic bacteriuria (4,6 versus 1,5%, p=0,02). Studies demonstrate greater susceptibility of diabetic than of nondiabetic animals to urinary tract infection. Suggested mechanisms are: decreased antibacterial activity due to the «sweet urine», defects in neutrophil function, increased adherence to uroepithelial cells. We have shown that bacteria indeed grow better in urine with glucose, however, very high concentrations inhibit growth and in the clinical study no effect of regulation of DM was documented. We also have shown that no difference exist in PMN function between diabetic women with/without and controls. However, Escherichia coli expressing type I fimbriae adhere better to uroepithelial cells of diabetic women.
-
1.
Murray E.G., Webb R., Swann. A disease of rabbits characterized by large mononuclear leucocytosis, caused by a hitherrto
-
2.
Hoepelman A.I.M, van Buren M., van den Broek J., Borleffs J.C.C. Bacteriuria in men infected with HIV-1 is related to their immune status (CD4+ cell count). Aids 1992; 6:179-84.
-
3.
Johnson J.R., Roberts P.L., Stamm W.E. P fimbriae and other virulence factors in E.coli urosepsis: association with patients' characteristics. J Infect Dis 1987; 156:225-9.
-
4.
Wheat L.J. Infection and diabetes mellitus. Diabetes Care 1980; 3:187-97.
-
5.
Carton J.A., Maradona J.A., Nuno F.J., et al. Diabetes mellitus and bacteraemia: A comparative study between diabetic and non-diabetic patients. EJM 1992; 1: 281-7.
-
6.
Forland M., Thomas V., Shelokov A. Urinary tract infections in patients with diabetes mellitus. Studies on antibody coating of bacteria. JAMA 1977; 238:1924-6.
-
7.
Forland M., Thomas V.L. The treatment of urinary tract infections in women with diabetes mellitus. Diabetes Care 1985; 8:499-506.
-
8.
Saiki J., Vaziri N.D., Barton C. Perinephric and intranephric abscesses: a review of the literature. West J Med 1982; 136:95-102.
-
9.
Zhanel G.G., Harding G.K., Nicolle L.E. Asymptomatic bacteriuria in patients with diabetes mellitus. Rev Infect Dis 1991; 13:150-4.
-
10.
Balasoiu D., Kessel К.С., Kats-Renaud H.J., Collet T.J., Hoepelman A.I. Granulocyte function in women with diabetes and asymptomatic bacteriuria. Diabetes Care 1997; 20:392-5
-
11.
Geerlings S.E., Stolk R.P., Camps M.J.L., Netten P.M., Hoekstra J.B.L., Bouter K.P., Bravenboer B., Collet T.J., Jansz A.R., Hoepelman I.M. Prevalence and risk factors for asymptomatic bacteriuria in women with diabetes mellitus. ICAAC 1999: abstr 607.
-
12.
Schmitt J.K., Fawcett C.J., Gullickson G. Asymptomatic bacteriuria and hemoglobin Al. Diabetes Care 1986; 9:518-20.
-
13.
Hansen R.O. Bacteriuria in diabetic and non-diabetic outpatients. Acta Med Scand 1964; 176:721-30.
-
14.
Joffe B.I., Seftel H.C., Distiller L.A. Asymptomatic bacteriuria in diabetes mellitus. S Afric Med J 1974; 48:1306-8.
-
15.
Vejisgaard R. Studies on urinary infection in diabetics. II. Significant bacteriuria in relation to long-term diabetic manifestations. Acta Med Scand 1966; 179:183-8.
-
16.
Batalla M.A., Balodimos M.C., Bradley R.F. Bacteriuria in diabetes mellitus. Diabetologia 1971; 7:297-301.
-
17.
Sawers J.S., Todd W.A., Kellett H.A., et al. Bacteriuria and autonomic nerve function in diabetic women. Diabetes Care 1986; 9:460-4.
-
18.
Geerlings S.E., Stolk R.P., Camps M.J.L., Netten P.M., Collet T.J., Hoepelman I.M. Asymptomatic bacteriuria in diabetic females precedes symptomatic urinary tract infection. ICAAC 1999: abstr 604.
-
19.
Zhanel G.G., Nicolle L.E., Harding G.K.M. Untreated asymptomatic bacteriuria (ABU) in women with diabetes mellitus (WWDM) is associated with high rates of pyelonephritis. ICAAC 1999: abstr 609.
-
20.
Raffel L., Pitsakis P., Levison S.P., Levison M.E. Experimental Candida albicans, Staphylococcus aureus, and Streptococcus faecalis pyelonephritis in diabetic rats. Infect Immun 1981; 34:773-9.
-
21.
Obana Y., Nishino T. The virulence of Enterobacter cloacae and Serratia marcescens in experimental bladder infection in diabetic mice. J Med Microbiol 1989; 30:105-9.
-
22.
Obana Y., Shibata К., Nishino T. Adherence of Serratia marcescens in the pathogenesis of urinary tract infections in diabetic mice. J Med Microbiol 1991; 35:93-7.
-
23.
Levison M.E., Pitsakis P.G. Effect of insulin treatment on the susceptibility of the diabetic rat to Escherichia соli-induced pyelonephritis. J Infect Dis 1984; 150:554-60.
-
24.
Geerlings S.E., Brouwer E.C., Gaastra W., Verhoef J., Hoepelman A.I.M. Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia соli; studies with urine from diabetic and non-diabetic individuals. J Med Microbiol 1999;48:535-9.
-
25.
Gargan R.A., Hamilton Miller J.M., Brumfitt W. Effect of pH and osmolality on in vitro phagocytosis and killing by neutrophils in urine. Infect Immun 1993; 61:8-12.
-
26.
Chernew I., Braude A.I. Depression of phagocytosis by solutes in concentrations found in kidney and urine. J Clin Invest 1962; 41:1945-53.
-
27.
Wang Q.N., Qiu Z.D. Infection in acute leukemia: an analysis of 433 episodes. Rev Infect Dis 1989; 11 Suppl 7:S1613-S20.
-
28.
Sheinfeld J., Schaeffer A.J., Cordon Cardo C., Rogatko A., Fair W.R. Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women. N Engl J Med 1989; 320:773-7.
-
29.
Lomberg H., Cedergren В., Leffler H., Nilsson В., Carlstrom A.S., Svanborg Eden C. Influence of blood group on the availability of receptors for attachment of uropathogenic Escherichia coli. Infect Immun 1986; 51:919-26.
-
30.
Stapleton A., Nudelman E., Clausen H., Hakomori S., Stamm W.E. Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status. J Clin Invest 1992; 90:965-72.
-
31.
Aly F.Z., Blackwell C.C., Mackenzie D.A., et al. Chronic atrophic oral candidiasis among patients with diabetes mellitus – role of secretor status. Epidemiol Infect 1991; 106:355-63.
-
32.
Parkkinen J., Virkola R., Korhonen T.K. Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins. Infect Immun 1988; 56:2623-30.
-
33.
Reinhart H.H., Spencer J.R., Zaki N.F., Sobel J.D. Quantitation of urinary Tamm-Horsfall protein in children with urinary tract infection. Eur Urol 1992; 22:194-9.
-
34.
Bernard A.M., Ouled A.A., Lauwerys R.R., Lambert A., Vandeleene B. Pronounced decrease of Tamm-Horsfall proteinuria in diabetics. Clin Chem 1987; 33:1264.
-
35.
Geerlings S.E. Cytokine secretion is impaired in women with diabetes mellitus. ICAAC 1999: abstr 1609.
-
36.
Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N Engl J Med 1993;329:1328-34.
-
37.
Gaymans R., Haverharm M.J., Valkenburg H.A., Goslings W.R.O. A prospective study of urinary tract infectious in a Dutch general practice. Lancet 1976, 25:674-7.
-
38.
Ronald A.R., Patullo L.S. The natural history of urinary tract infections in adults. Infect Dis Clin North Am 1991;3:299-312.